Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : FTH1
Therapeutic Area : Hematology
Study Phase : Undisclosed
Recipient : Sidero Bioscience
Deal Size : Undisclosed
Deal Type : Agreement
Details : The agreement provides SRS exclusive rights for sales, marketing, and distribution of Sidero’s patented biologic iron, BioFeTM, for the management of iron deficiency and related disorders in India and Southeast Asia.
Brand Name : BioFe
Molecule Type : Large molecule
Upfront Cash : Undisclosed
October 13, 2020
Lead Product(s) : FTH1
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Recipient : Sidero Bioscience
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?
Reset All
